MSN launches beta health management site

Share this article:
MSN launches beta health management site
MSN launches beta health management site

MSN today announced the launch of My Health Info, a new website for consumers that incorporates Microsoft's HealthVault profiles into a more comprehensive offering, which includes tools and widgets to organize health information.

The site, located on MSN's health and fitness homepage, provides tools for monitoring condition specific variables, such as high blood pressure or diabetes, as well as general health stats, such as body-mass index. Consumers can customize individual dashboards by adding or deleting widgets. Advertising and sponsorships will be incorporated into the site eventually, once My Health Info concludes its testing phase, according to Lisa Gurry, director, MSN.

The website also offers savings on HealthVault-enabled devices, such as free delivery or rebates on pedometers and blood pressure monitors. The site allows caregivers to access profiles of multiple family members at one time, and delivers health news based on topics of interest. The site isn't available on mobile devices yet, but Gurry expects Microsoft Silverlight, a multi-platform video and graphics technology and partner on My Health Info, to add that capability moving forward. IQ Interactive's Atlanta, Georgia office also worked on the design and engineering of the site.

“Building on the power of HealthVault, My Health Info demonstrates how we are continuing to provide consumers with the trusted and relevant tools they need to make more informated decisions in support of their health and the health of their families,” said David Cerino, general manager of consumer health, Microsoft health solutions group, in a statement.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...